The overexpression of transcription-regulatory oncoprotein C-myc has been reported in most types of human malignancies, including ovarian cancers, which controls genes involved in cell cycle progression, cell growth and apoptosis [79–82]. This evidence concerns the gene MYC and ovarian carcinoma.